BR9814284A - Composições e métodos para regulação de fagocitose e expressão de icam-1 - Google Patents

Composições e métodos para regulação de fagocitose e expressão de icam-1

Info

Publication number
BR9814284A
BR9814284A BR9814284-4A BR9814284A BR9814284A BR 9814284 A BR9814284 A BR 9814284A BR 9814284 A BR9814284 A BR 9814284A BR 9814284 A BR9814284 A BR 9814284A
Authority
BR
Brazil
Prior art keywords
icam
expression
phagocytosis
methods
compositions
Prior art date
Application number
BR9814284-4A
Other languages
English (en)
Inventor
Seiberg Miri
Stanley S Shapiro
Magdalena Eisinger
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Publication of BR9814284A publication Critical patent/BR9814284A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4826—Trypsin (3.4.21.4) Chymotrypsin (3.4.21.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Patente de Invenção:<B>"COMPOSIçõES E MéTODOS PARA REGULAçãO DE FAGOCITOSE E EXPRESSãO DE ICAM-1"<D>. Esta invenção provê composições de substância para o tratamento e prevenção de certos distúrbios de mamífero melhorados ou por um aumento ou diminuição em fagocitose ou expressão de ICAM-1 em células apropriadas. Esta invenção também provê método de alteração do nível de fagocitose ou de expressão de ICAM-1 em uma célula. Esta invenção ulteriormente provê métodos de tratamento e prevenção de distúrbios de mamífero afetados pela alteração de fagocitose ou expressão de ICAM-1. Os presentes métodos e composição de substância todos relacionam-se com o uso de agentes que especificamente aumentam ou diminuem fagocitose ou expressão de ICAM-1. Finalmente, esta invenção provê artigos de fabricação correlatos.
BR9814284-4A 1997-12-16 1998-12-10 Composições e métodos para regulação de fagocitose e expressão de icam-1 BR9814284A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6979797P 1997-12-16 1997-12-16
PCT/US1998/026255 WO1999030729A1 (en) 1997-12-16 1998-12-10 Compositions and methods for regulating phagocytosis and icam-1 expression

Publications (1)

Publication Number Publication Date
BR9814284A true BR9814284A (pt) 2000-10-03

Family

ID=22091272

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9814284-4A BR9814284A (pt) 1997-12-16 1998-12-10 Composições e métodos para regulação de fagocitose e expressão de icam-1

Country Status (13)

Country Link
EP (1) EP1037653B1 (pt)
JP (1) JP4689039B2 (pt)
KR (1) KR100601810B1 (pt)
CN (1) CN1188164C (pt)
AR (1) AR017216A1 (pt)
AU (4) AU1722099A (pt)
BR (1) BR9814284A (pt)
CA (1) CA2314899A1 (pt)
DE (1) DE69835832T2 (pt)
ES (1) ES2273445T3 (pt)
TW (1) TW590775B (pt)
WO (1) WO1999030729A1 (pt)
ZA (1) ZA9811537B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8039026B1 (en) 1997-07-28 2011-10-18 Johnson & Johnson Consumer Companies, Inc Methods for treating skin pigmentation
US8106094B2 (en) 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
US6750229B2 (en) 1998-07-06 2004-06-15 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin pigmentation
US8093293B2 (en) 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
IL144577A0 (en) 1999-01-27 2002-05-23 Ortho Mcneil Pharm Inc Peptidyl heterocyclic ketones useful as tryptase inhibitors
US7985404B1 (en) 1999-07-27 2011-07-26 Johnson & Johnson Consumer Companies, Inc. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
CA2358958C (en) † 1999-11-05 2012-07-31 Johnson & Johnson Consumer Companies, Inc. Soy depigmenting and skin care compositions
US8431550B2 (en) 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
US7192615B2 (en) 2001-02-28 2007-03-20 J&J Consumer Companies, Inc. Compositions containing legume products
JP2006347926A (ja) * 2005-06-14 2006-12-28 Ichimaru Pharcos Co Ltd ファゴサイトーシス抑制剤
JP2011214909A (ja) * 2010-03-31 2011-10-27 Daiichi Sankyo Healthcare Co Ltd ケラチノサイトのメラノソーム取り込み輸送の検出方法
TWI493036B (zh) * 2013-12-24 2015-07-21 Ind Tech Res Inst 含一ｃｄ５４表現之報導系統之免疫細胞的應用以及一經選殖之新穎細胞

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63148952A (ja) * 1986-12-12 1988-06-21 Terumo Corp 加工大豆の製法
JP2618657B2 (ja) * 1987-10-02 1997-06-11 株式会社資生堂 抗色素沈着外用剤
EP0421021A1 (de) * 1989-10-06 1991-04-10 MUCOS EMULSIONSGESELLSCHAFT m.b.H. Verwendung katabolischer Enzyme zur Aktivierung von Makrophagen und/oder NK-Zellen, ein diese Enzyme enthaltendes Arzneimittel sowie durch diese Enzyme aktivierte Makrophage und/oder NK-zelle
JP3032566B2 (ja) * 1990-11-01 2000-04-17 株式会社資生堂 皮膚外用剤
US6030612A (en) * 1994-11-22 2000-02-29 Phairson Medical Inc. Antimicrobial uses of multifunctional enzyme
JPH07255406A (ja) * 1994-03-24 1995-10-09 Hisatomi Shokuhin Kogyo Kk 高度不飽和油脂強化大豆加工食品の製造方法

Also Published As

Publication number Publication date
AU2003204412A1 (en) 2003-07-03
CA2314899A1 (en) 1999-06-24
ZA9811537B (en) 2000-06-27
DE69835832D1 (de) 2006-10-19
AU1722099A (en) 1999-07-05
KR20010015882A (ko) 2001-02-26
AU2006203246A1 (en) 2006-08-17
ES2273445T3 (es) 2007-05-01
DE69835832T2 (de) 2007-04-05
JP2002508331A (ja) 2002-03-19
AU2010200198A1 (en) 2010-02-04
CN1282254A (zh) 2001-01-31
EP1037653A1 (en) 2000-09-27
CN1188164C (zh) 2005-02-09
TW590775B (en) 2004-06-11
KR100601810B1 (ko) 2006-07-19
WO1999030729A1 (en) 1999-06-24
JP4689039B2 (ja) 2011-05-25
EP1037653B1 (en) 2006-09-06
AR017216A1 (es) 2001-08-22

Similar Documents

Publication Publication Date Title
BR0015416A (pt) Composições contendo derivados do ácido hidroxieicosa tetraenóico e métodos de uso no tratamento de distúrbios de olhos secos
DE69430440T2 (de) Zusammensetzungen zur inhibition von retroviraler verbreitung, die 2&#39;,3&#39;-dideoxy-inosin und hydroxyharnstoff enthalten
BR9814284A (pt) Composições e métodos para regulação de fagocitose e expressão de icam-1
BRPI9913945B8 (pt) Composição farmacêutica rapidamente atuante para a administração sublingual de um agente farmacêutico para o tratamento de distúrbios agudos
DE69736814D1 (de) Adipogenische differenzierung von humanen mesenchymalen stammzellen
DE69914726D1 (de) Zusammensetzung zur regulierung des hauterscheinungsbildes
ATE393831T1 (de) Zusammensetzung zur in vivo erzeugung von therapeutischen produkten
BR0014078A (pt) Inibidores de fator xa
ATE413179T1 (de) Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden
ID29393A (id) Komposisi pengobatan kanker dan metoda penggunaan minyak-minyak esensil tanaman alamiah
BR0315688A (pt) Compostos, composições farmacêuticas e seus usos no tratamento ou prevenção de doenças ou condições de proliferação celular metabólicas
BRPI0411319A (pt) compostos terapeuticamente ativos e sua utilização
KR19980700976A (pt)
BR0001925A (pt) Utilização de pelo menos um composto, composição cosmética desodorante, utilização de uma composição, utilização do 3,5-di-hidroxiestilbeno, processo para tratar os odores axilares humanos, composto e composição cosmética
BR9813684A (pt) Processo para tratar o glaucoma glc1a, e, composição para controlar o glaucoma glc1a.
NO953093D0 (no) Forbindelser med både sterk kalsiumantagonist- og antioksidantvirkning, samt anvendelse derav som cellebeskyttende midler
DK0920309T3 (da) Konjugeret linolensyre til bevaring eller forøgelse af mineralindhold i knogler
BR0114978A (pt) Composições e métodos que são úteis no tratamento de condições ou doenças inflamatórias, metabólicas, e proliferativas celulares
BR0109211A (pt) Compostos com atividade 5-ht1a úteis para o tratamento de distúrbios da retina externa
BR9910329A (pt) Composto, composição farmacêutica, processo para estimular a liberação do hormÈnio de crescimento da pituitária de um mamìfero, e, uso de um composto
ATE253820T1 (de) Wirkstoffhaltige komposition sowie deren herstellung und verwendung
HUP9701611A2 (hu) Nagy elektrolittartalmú V/O emulzió, alkalmazása bőrkozmetikai készítményekben, különösen irritáció és/vagy érzékeny bőr kezelésére
BR9809284A (pt) Construto e processo para expressão de polinucleotìdeo em altos nìveis
BR9914158A (pt) Composição antibiótica para o tratamento dos olhos, ouvidos e nariz
CA2130967A1 (en) Long life deodorant composition

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIDO O PRESENTE PEDIDO DE ACORDO COM O ART. 8O COMBINADO COM O ART. 13 E ART. 25 DA LPI 9279/96.

B12B Appeal against refusal [chapter 12.2 patent gazette]